{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "05", "@timestamp": "2020-06-05T06:41:01.000001-04:00", "@year": "2020", "@month": "06"}, "ait:date-sort": {"@day": "01", "@year": "2016", "@month": "06"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "Department of Drug Safety Sciences"}, {"xocs:funding-agency-matched-string": "Nagoya University Graduate School of Medicine , Nagoya, Japan", "xocs:funding-id": "TG 55-09-56-002D"}, {"xocs:funding-agency-matched-string": "National Nanotechnology"}, {"xocs:funding-agency-matched-string": "Research, Development and Engineering Fund"}, {"xocs:funding-agency-matched-string": "Chulalongkorn University", "xocs:funding-agency-acronym": "CU", "xocs:funding-agency": "Chulalongkorn University", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}, {"xocs:funding-agency-matched-string": "National Science and Technology Development Agency", "xocs:funding-agency-acronym": "\u0e2a\u0e27\u0e17\u0e0a", "xocs:funding-agency": "National Science and Technology Development Agency", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004192", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}, {"xocs:funding-agency-matched-string": "National Research Council of Thailand", "xocs:funding-agency-acronym": "NRCT", "xocs:funding-agency": "National Research Council of Thailand", "xocs:funding-id": "NRCT 2013-83", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100004704", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}], "xocs:funding-addon-generated-timestamp": "2021-05-08T17:21:32.651589Z", "xocs:funding-text": "This work was financially supported by Grants-in-Aid for Scientific Research from the National Research Council of Thailand (grant number NRCT 2013-83 ); and partly by the Research, Development and Engineering Fund through the National Nanotechnology, the National Science and Technology Development Agency (NSTDA), Thailand, the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphisek Somphot Endowment fund), and the Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine , Nagoya, Japan. Abhiruj Chiangsom received Capital Projects TGIST Scholarship (grant number TG 55-09-56-002D ) from NSTDA. We thank Dr. Ian S. Haworth (University of Southern California) for editing the manuscript.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "Thailand", "postal-code": "10330", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology and Physiology"}, {"$": "Faculty of Pharmaceutical Sciences"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "107494420"}, "@dptid": "107494420"}, "author": [{"ce:given-name": "Abhiruj", "preferred-name": {"ce:given-name": "Abhiruj", "ce:initials": "A.", "ce:surname": "Chiangsom", "ce:indexed-name": "Chiangsom A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "@type": "auth", "ce:surname": "Chiangsom", "@auid": "57189455670", "ce:indexed-name": "Chiangsom A."}, {"ce:given-name": "Somsong", "preferred-name": {"ce:given-name": "Somsong", "ce:initials": "S.", "ce:surname": "Lawanprasert", "ce:indexed-name": "Lawanprasert S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Lawanprasert", "@auid": "6504371267", "ce:indexed-name": "Lawanprasert S."}, {"ce:given-name": "Rataya", "preferred-name": {"ce:given-name": "Rataya", "ce:initials": "R.", "ce:surname": "Luechapudiporn", "ce:indexed-name": "Luechapudiporn R."}, "@seq": "5", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Luechapudiporn", "@auid": "13606193100", "@orcid": "0000-0001-9120-9413", "ce:indexed-name": "Luechapudiporn R."}]}, {"affiliation": {"country": "Japan", "postal-code": "466-8550", "@afid": "60161458", "@country": "jpn", "city": "Nagoya", "organization": [{"$": "Department of Drug Safety Sciences"}, {"$": "Nagoya University Graduate School of Medicine"}], "affiliation-id": {"@afid": "60161458", "@dptid": "124489819"}, "@dptid": "124489819"}, "author": [{"ce:given-name": "Shingo", "preferred-name": {"ce:given-name": "Shingo", "ce:initials": "S.", "ce:surname": "Oda", "ce:indexed-name": "Oda S."}, "@seq": "3", "ce:initials": "S.", "@date-locked": "2017-06-14T06:10:03.592", "@_fa": "true", "@type": "auth", "ce:surname": "Oda", "@auid": "36661277500", "ce:indexed-name": "Oda S."}, {"ce:given-name": "Tsuyoshi", "preferred-name": {"ce:given-name": "Tsuyoshi", "ce:initials": "T.", "ce:surname": "Yokoi", "ce:indexed-name": "Yokoi T."}, "@seq": "6", "ce:initials": "T.", "@_fa": "true", "@type": "auth", "ce:surname": "Yokoi", "@auid": "7201620434", "ce:indexed-name": "Yokoi T."}]}, {"affiliation": {"country": "Thailand", "postal-code": "12120", "@afid": "60004391", "@country": "tha", "city": "Pathum Thani", "organization": [{"$": "National Nanotechnology Center"}, {"$": "National Science and Technology Development Agency (NSTDA)"}], "affiliation-id": [{"@afid": "60004391"}, {"@afid": "60017285"}]}, "author": [{"ce:given-name": "Kornphimol", "preferred-name": {"ce:given-name": "Kornphimol", "ce:initials": "K.", "ce:surname": "Kulthong", "ce:indexed-name": "Kulthong K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "@type": "auth", "ce:surname": "Kulthong", "@auid": "35784698300", "ce:indexed-name": "Kulthong K."}, {"ce:given-name": "Rawiwan", "preferred-name": {"ce:given-name": "Rawiwan", "ce:initials": "R.", "ce:surname": "Maniratanachote", "ce:indexed-name": "Maniratanachote R."}, "@seq": "7", "ce:initials": "R.", "@_fa": "true", "@type": "auth", "ce:surname": "Maniratanachote", "@auid": "8936773600", "ce:indexed-name": "Maniratanachote R."}]}], "citation-title": "Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450", "abstracts": "\u00a9 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.Effects of the hydroethanolic extract of Phikud Navakot (PN), a Thai traditional remedy, on human cytochrome P450s (CYPs) were investigated in vitro. Selective substrates of CYPs were used to investigate the effects and kinetics of PN on CYP inhibition using human liver microsomes. Primary human hepatocytes were used to assess the inductive effects of PN on CYP enzyme activities and protein expressions. The results showed that PN inhibited the activities of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 with half maximal inhibitory concentration (IC50) values of 13, 62, 67, and 88 \u03bcg/mL, respectively. Meanwhile, it had no effect on the activities of CYP2C19 and CYP2E1 (IC50 > 1 mg/mL). PN exhibited competitive inhibition of CYP1A2 (Ki = 34 \u03bcg/mL), mixed type inhibition of CYP2C9 and CYP2D6 (Ki = 80 and 12 \u03bcg/mL, respectively), and uncompetitive inhibition of CYP3A4 (Ki = 150 \u03bcg/mL). PN did not have an inductive effect on CYP1A2, CYP2C9, CYP2C19 and CYP3A4 in primary human hepatocytes, which is an advantageous characteristic of the extract. However the extract may cause herb-drug interactions via inhibition of CYP1A2, CYP2C9, CYP2D6 and CYP3A4, and precautions should be taken when PN is coadministered with drugs that are metabolized by these CYP enzymes.", "correspondence": {"affiliation": {"country": "Thailand", "postal-code": "12120", "@country": "tha", "city": "Pathum Thani", "organization": [{"$": "National Nanotechnology Center"}, {"$": "National Science and Technology Development Agency (NSTDA)"}]}, "person": {"ce:given-name": "Rawiwan", "ce:initials": "R.", "ce:surname": "Maniratanachote", "ce:indexed-name": "Maniratanachote R."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Cytochrome P450", "@xml:lang": "eng"}, {"$": "Drug interaction", "@xml:lang": "eng"}, {"$": "Induction", "@xml:lang": "eng"}, {"$": "Inhibition", "@xml:lang": "eng"}, {"$": "Phikud Navakot", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "https://www.jstage.jst.go.jp/browse/dmpk", "@type": "email"}}, "translated-sourcetitle": {"$": "Drug Metabolism and Pharmacokinetics", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "31", "@issue": "3"}, "pagerange": {"@first": "210", "@last": "217"}}, "@type": "j", "sourcetitle": "Drug Metabolism and Pharmacokinetics", "publicationdate": {"month": "06", "year": "2016", "date-text": {"@xfab-added": "true", "$": "1 June 2016"}, "day": "01"}, "codencode": "DMPRB", "sourcetitle-abbrev": "Drug Metab. Pharmacokinet.", "@country": "jpn", "issn": [{"$": "18800920", "@type": "electronic"}, {"$": "13474367", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Japanese Society for the Study of Xenobiotics", "ce:e-address": {"$": "jssx@imic.or.jp", "@type": "email"}}, "@srcid": "144956"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": [{"$": "3004"}, {"$": "3003"}, {"$": "2736"}]}, {"@type": "SUBJABBR", "classification": [{"$": "PHAR"}, {"$": "MEDI"}]}]}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "9035-51-2", "chemical-name": "cytochrome P450"}, {"cas-registry-number": "329736-03-0", "chemical-name": "cytochrome P450 3A4"}, {"cas-registry-number": [{"$": "147-84-2"}, {"$": "148-18-5"}, {"$": "3699-30-7"}, {"$": "392-74-5"}], "chemical-name": "diethyldithiocarbamic acid"}, {"cas-registry-number": "80288-49-9", "chemical-name": "furafylline"}, {"cas-registry-number": "65277-42-1", "chemical-name": "ketoconazole"}, {"cas-registry-number": [{"$": "73590-58-6"}, {"$": "95510-70-6"}], "chemical-name": "omeprazole"}, {"cas-registry-number": "56-54-2", "chemical-name": "quinidine"}, {"cas-registry-number": "13292-46-1", "chemical-name": "rifampicin"}, {"cas-registry-number": "526-08-9", "chemical-name": "sulfaphenazole"}, {"cas-registry-number": [{"$": "53885-35-1"}, {"$": "55142-85-3"}], "chemical-name": "ticlopidine"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Cytochrome P-450 Enzyme Inducers"}, {"chemical-name": "Cytochrome P-450 Enzyme Inhibitors"}, {"chemical-name": "Cytochrome P-450 Enzyme System"}, {"chemical-name": "phikud navakot"}, {"chemical-name": "Plant Extracts"}]}]}, "manufacturergroup": {"manufacturers": {"@type": "MNF", "manufacturer": [{"@country": "jpn", "$": "Daiichi Seiyaku"}, {"@country": "jpn", "$": "Funakoshi"}, {"@country": "jpn", "$": "Wako"}, {"@country": "usa", "$": "Cayman"}, {"@country": "usa", "$": "Sigma Aldrich"}]}}}, "grantlist": {"@complete": "y", "grant-text": {"$": "This work was financially supported by Grants-in-Aid for Scientific Research from the National Research Council of Thailand (grant number NRCT 2013-83); and partly by the Research, Development and Engineering Fund through the National Nanotechnology, the National Science and Technology Development Agency (NSTDA), Thailand, the 90th Anniversary of Chulalongkorn University Fund (Ratchadaphisek Somphot Endowment fund), and the Department of Drug Safety Sciences, Nagoya University Graduate School of Medicine, Nagoya, Japan. Abhiruj Chiangsom received Capital Projects TGIST Scholarship (grant number TG 55-09-56-002D) from NSTDA. We thank Dr. Ian S. Haworth (University of Southern California) for editing the manuscript.", "@xml:lang": "eng"}, "grant": {"grant-acronym": "NSTDA", "grant-agency": "National Science and Technology Development Agency"}}}, "item-info": {"copyright": {"$": "Copyright 2016 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYS"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}, {"$": "MEDL"}], "history": {"date-created": {"@day": "08", "@timestamp": "BST 15:49:16", "@year": "2016", "@month": "12"}}, "itemidlist": {"itemid": [{"$": "610569379", "@idtype": "PUI"}, {"$": "651007758", "@idtype": "CAR-ID"}, {"$": "20160406581", "@idtype": "EMBASE"}, {"$": "2016141144", "@idtype": "REAXYS"}, {"$": "20161275077", "@idtype": "REAXYSCAR"}, {"$": "2016161566", "@idtype": "RMC"}, {"$": "84971320923", "@idtype": "SCP"}, {"$": "84971320923", "@idtype": "SGR"}, {"$": "614989264", "@idtype": "PUIsecondary"}, {"$": "27212065", "@idtype": "MEDL"}], "ce:pii": "S1347436716300179", "ce:doi": "10.1016/j.dmpk.2016.04.002"}}, "tail": {"bibliography": {"@refcount": "28", "reference": [{"ref-fulltext": "National Drug Committee of Thailand. List of herbal medicinal products A.D. 2013. Bangkok: National Drug Committee of Thailand.", "@id": "1", "ref-info": {"refd-itemidlist": {"itemid": {"$": "84973432394", "@idtype": "SGR"}}, "ref-text": "National Drug Committee of Thailand Bangkok: National Drug Committee of Thailand", "ref-sourcetitle": "List of Herbal Medicinal Products A.D. 2013"}}, {"ref-fulltext": "P. Nusuetrong, U. Sotanaphun, and P. Tep-areenan Effects of Phikud Navakot extract on vascular reactivity in the isolated rat aorta J Med Assoc Thai 95 2012 S1 S7", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Effects of Phikud Navakot extract on vascular reactivity in the isolated rat aorta"}, "refd-itemidlist": {"itemid": {"$": "84876900461", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "95"}, "pagerange": {"@first": "S1", "@last": "S7"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Nusuetrong", "ce:indexed-name": "Nusuetrong P."}, {"@seq": "2", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Sotanaphun", "ce:indexed-name": "Sotanaphun U."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Tep-Areenan", "ce:indexed-name": "Tep-Areenan P."}]}, "ref-sourcetitle": "J Med Assoc Thai"}}, {"ref-fulltext": "N. Nalinratana, W. Kaewprem, S. Tongumpai, R. Luechapudiporn, U. Sotanaphun, and D. Meksuriyen Synergistic antioxidant action of Phikud Navakot ameliorates hydrogen peroxide-induced stress in human endothelial cells Integr Med Res 3 2014 74 82", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Synergistic antioxidant action of Phikud Navakot ameliorates hydrogen peroxide-induced stress in human endothelial cells"}, "refd-itemidlist": {"itemid": {"$": "84925294963", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "74", "@last": "82"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Nalinratana", "ce:indexed-name": "Nalinratana N."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Kaewprem", "ce:indexed-name": "Kaewprem W."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Tongumpai", "ce:indexed-name": "Tongumpai S."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Luechapudiporn", "ce:indexed-name": "Luechapudiporn R."}, {"@seq": "5", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Sotanaphun", "ce:indexed-name": "Sotanaphun U."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Meksuriyen", "ce:indexed-name": "Meksuriyen D."}]}, "ref-sourcetitle": "Integr Med Res"}}, {"ref-fulltext": "K. Kengkoom, K. Chaimongkolnukul, S. Cherdyu, R. Inpunkaew, and S. Ampawong Acute and sub-chronic oral toxicity studies of the extracts from herbs in Phikud Navakot Afr J Biotechnol 11 2012 10903 10911", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Acute and sub-chronic oral toxicity studies of the extracts from herbs in Phikud Navakot"}, "refd-itemidlist": {"itemid": {"$": "84907373376", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "10903", "@last": "10911"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kengkoom", "ce:indexed-name": "Kengkoom K."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Chaimongkolnukul", "ce:indexed-name": "Chaimongkolnukul K."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Cherdyu", "ce:indexed-name": "Cherdyu S."}, {"@seq": "4", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Inpunkaew", "ce:indexed-name": "Inpunkaew R."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ampawong", "ce:indexed-name": "Ampawong S."}]}, "ref-sourcetitle": "Afr J Biotechnol"}}, {"ref-fulltext": "K. Kengkoom, and S. Ampawong Chronic ingestion of high dosed Phikud Navakot extraction induces mesangiolysis in rats with alteration of AQP1 and Hsp60 expressions Biomed Res Int 2015 462387", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Chronic ingestion of high dosed Phikud Navakot extraction induces mesangiolysis in rats with alteration of AQP1 and Hsp60 expressions"}, "refd-itemidlist": {"itemid": {"$": "84925337180", "@idtype": "SGR"}}, "ref-text": "462387", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kengkoom", "ce:indexed-name": "Kengkoom K."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Ampawong", "ce:indexed-name": "Ampawong S."}]}, "ref-sourcetitle": "Biomed Res Int"}}, {"ref-fulltext": "U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research Guidance for industry on drug interaction studies: study design, data analysis, implications for dosing and labeling recommendations 2012 http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-website": {"ce:e-address": {"$": "http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm292362.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84865415281", "@idtype": "SGR"}}, "ref-text": "U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research", "ref-sourcetitle": "Guidance for Industry on Drug Interaction Studies: Study Design, Data Analysis, Implications for Dosing and Labeling Recommendations"}}, {"ref-fulltext": "P. Kumnerdnon, P. Rojsitthisak, N. Niwattisaiwong, U. Sotanaphun, J. Chatchawalsaisin, and N. Sutanthavibul Validation of an RP-HPLC method for quantitative analysis of Phikud Navakot extract using the standard addition method Thai J Pharm Sci 40 2016 26 31", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Validation of an RP-HPLC method for quantitative analysis of Phikud Navakot extract using the standard addition method"}, "refd-itemidlist": {"itemid": {"$": "84963877867", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "26", "@last": "31"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Kumnerdnon", "ce:indexed-name": "Kumnerdnon P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Rojsitthisak", "ce:indexed-name": "Rojsitthisak P."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Niwattisaiwong", "ce:indexed-name": "Niwattisaiwong N."}, {"@seq": "4", "ce:initials": "U.", "@_fa": "true", "ce:surname": "Sotanaphun", "ce:indexed-name": "Sotanaphun U."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Chatchawalsaisin", "ce:indexed-name": "Chatchawalsaisin J."}, {"@seq": "6", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Sutanthavibul", "ce:indexed-name": "Sutanthavibul N."}]}, "ref-sourcetitle": "Thai J Pharm Sci"}}, {"ref-fulltext": "K. Kulthong, R. Maniratanachote, Y. Kobayashi, T. Fukami, and T. Yokoi Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity Xenobiotica 42 2012 854 862", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Effects of silver nanoparticles on rat hepatic cytochrome P450 enzyme activity"}, "refd-itemidlist": {"itemid": {"$": "84865023160", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "42"}, "pagerange": {"@first": "854", "@last": "862"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kulthong", "ce:indexed-name": "Kulthong K."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Maniratanachote", "ce:indexed-name": "Maniratanachote R."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Kobayashi", "ce:indexed-name": "Kobayashi Y."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Fukami", "ce:indexed-name": "Fukami T."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Yokoi", "ce:indexed-name": "Yokoi T."}]}, "ref-sourcetitle": "Xenobiotica"}}, {"ref-fulltext": "S. Sangthong, A. Treenert, S. Suwannakul, and B. Sethabouppha Preliminary screening test for the effect of 5 Thai herbal crude extracts (Artemisia pallens, Ligusticum chuanxiong, Dischidia rafflesiana, Atractylodes lancea, Plantago ovate) on rat CYP3A4 enzyme activity in vitro Bachelor's Senior Project 2010 Faculty of Pharmaceutical Sciences, Ubon Rajathani University", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "refd-itemidlist": {"itemid": {"$": "84973422396", "@idtype": "SGR"}}, "ref-text": "Bachelor's Senior Project Faculty of Pharmaceutical Sciences, Ubon Rajathani University", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Sangthong", "ce:indexed-name": "Sangthong S."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Treenert", "ce:indexed-name": "Treenert A."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Suwannakul", "ce:indexed-name": "Suwannakul S."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Sethabouppha", "ce:indexed-name": "Sethabouppha B."}]}, "ref-sourcetitle": "Preliminary Screening Test for the Effect of 5 Thai Herbal Crude Extracts (Artemisia Pallens, Ligusticum Chuanxiong, Dischidia Rafflesiana, Atractylodes Lancea, Plantago Ovate) on Rat CYP3A4 Enzyme Activity in Vitro"}}, {"ref-fulltext": "P. Silaket, P. Thitiyarak, S. Suwannakul, and B. Sethabouppha Preliminary screening test for the effect of Kote sor and 4 Thai herbal extract on rat CYP3A4 enzyme activity in-vitro Bachelor's Senior Project 2010 Faculty of Pharmaceutical Sciences, Ubon Rajathani University", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "refd-itemidlist": {"itemid": {"$": "84973421669", "@idtype": "SGR"}}, "ref-text": "Bachelor's Senior Project Faculty of Pharmaceutical Sciences, Ubon Rajathani University", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Silaket", "ce:indexed-name": "Silaket P."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Thitiyarak", "ce:indexed-name": "Thitiyarak P."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Suwannakul", "ce:indexed-name": "Suwannakul S."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Sethabouppha", "ce:indexed-name": "Sethabouppha B."}]}, "ref-sourcetitle": "Preliminary Screening Test for the Effect of Kote Sor and 4 Thai Herbal Extract on Rat CYP3A4 Enzyme Activity In-vitro"}}, {"ref-fulltext": "A. Kumar, K. Lakshman, K.N. Jayaveera, S.N. Mani Tripathi, and K.V. Satish Estimation of gallic acid, rutin and quercetin in Terminalia chebula by HPTLC JJPS 3 2010 63 68", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Estimation of gallic acid, rutin and quercetin in Terminalia chebula by HPTLC"}, "refd-itemidlist": {"itemid": {"$": "77953425535", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "63", "@last": "68"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kumar", "ce:indexed-name": "Kumar A."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Lakshman", "ce:indexed-name": "Lakshman K."}, {"@seq": "3", "ce:initials": "K.N.", "@_fa": "true", "ce:surname": "Jayaveera", "ce:indexed-name": "Jayaveera K.N."}, {"@seq": "4", "ce:initials": "S.N.", "@_fa": "true", "ce:surname": "Mani Tripathi", "ce:indexed-name": "Mani Tripathi S.N."}, {"@seq": "5", "ce:initials": "K.V.", "@_fa": "true", "ce:surname": "Satish", "ce:indexed-name": "Satish K.V."}]}, "ref-sourcetitle": "JJPS"}}, {"ref-fulltext": "I. Stupans, H.W. Tan, A. Kirlich, K. Tuck, P. Hayball, and M. Murray Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid J Pharm Pharmacol 54 2002 269 275", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid"}, "refd-itemidlist": {"itemid": {"$": "0036171773", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "54"}, "pagerange": {"@first": "269", "@last": "275"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Stupans", "ce:indexed-name": "Stupans I."}, {"@seq": "2", "ce:initials": "H.W.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan H.W."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kirlich", "ce:indexed-name": "Kirlich A."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Tuck", "ce:indexed-name": "Tuck K."}, {"@seq": "5", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Hayball", "ce:indexed-name": "Hayball P."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Murray", "ce:indexed-name": "Murray M."}]}, "ref-sourcetitle": "J Pharm Pharmacol"}}, {"ref-fulltext": "K. Ishihara, H. Kushida, M. Yuzurihara, Y. Wakui, T. Yanagisawa, H. Kamei, and et al. Interaction of drugs and Chinese herbs: pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica J Pharm Pharmacol 52 2000 1023 1029", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "Interaction of drugs and Chinese herbs: Pharmacokinetic changes of tolbutamide and diazepam caused by extract of Angelica dahurica"}, "refd-itemidlist": {"itemid": {"$": "0033811070", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "52"}, "pagerange": {"@first": "1023", "@last": "1029"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Ishihara", "ce:indexed-name": "Ishihara K."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kushida", "ce:indexed-name": "Kushida H."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Yuzurihara", "ce:indexed-name": "Yuzurihara M."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Wakui", "ce:indexed-name": "Wakui Y."}, {"@seq": "5", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Yanagisawa", "ce:indexed-name": "Yanagisawa T."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kamei", "ce:indexed-name": "Kamei H."}], "et-al": null}, "ref-sourcetitle": "J Pharm Pharmacol"}}, {"ref-fulltext": "M. Martignoni, G.M. Groothuis, and R.D. Kanter Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction Expert Opin Drug Metab Toxicol 2 2006 875 894", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction"}, "refd-itemidlist": {"itemid": {"$": "33845473315", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2"}, "pagerange": {"@first": "875", "@last": "894"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Martignoni", "ce:indexed-name": "Martignoni M."}, {"@seq": "2", "ce:initials": "G.M.", "@_fa": "true", "ce:surname": "Groothuis", "ce:indexed-name": "Groothuis G.M."}, {"@seq": "3", "ce:initials": "R.D.", "@_fa": "true", "ce:surname": "Kanter", "ce:indexed-name": "Kanter R.D."}]}, "ref-sourcetitle": "Expert Opin Drug Metab Toxicol"}}, {"ref-fulltext": "U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research Guidance for industry on drug interaction studies: study design, data analysis, and implications for dosing and labeling 2006 http://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0344-gdl0001.pdf", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-website": {"ce:e-address": {"$": "http://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0344-gdl0001.pdf", "@type": "email"}}, "refd-itemidlist": {"itemid": {"$": "84865415281", "@idtype": "SGR"}}, "ref-text": "U.S. Department of Health and Human Services, Food and Drug Administration, and Center for Drug Evaluation and Research", "ref-sourcetitle": "Guidance for Industry on Drug Interaction Studies: Study Design, Data Analysis, and Implications for Dosing and Labeling"}}, {"ref-fulltext": "V.A. Eagling, J.F. Tjia, and D.J. Back Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes Br J Clin Pharm 45 1998 107 114", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes"}, "refd-itemidlist": {"itemid": {"$": "0031962621", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "45"}, "pagerange": {"@first": "107", "@last": "114"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "V.A.", "@_fa": "true", "ce:surname": "Eagling", "ce:indexed-name": "Eagling V.A."}, {"@seq": "2", "ce:initials": "J.F.", "@_fa": "true", "ce:surname": "Tjia", "ce:indexed-name": "Tjia J.F."}, {"@seq": "3", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Back", "ce:indexed-name": "Back D.J."}]}, "ref-sourcetitle": "Br J Clin Pharm"}}, {"ref-fulltext": "S. Iwakawa, K. Miyakita, Y. Hashimoto, and T. Kuroda Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3 Biol Pharm Bull 29 2006 1983 1985", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Effect of glimepiride and glibenclamide on S-warfarin 7-hydroxylation by human liver microsomes, recombinant human CYP2C9.1 and CYP2C9.3"}, "refd-itemidlist": {"itemid": {"$": "33748369900", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "1983", "@last": "1985"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Iwakawa", "ce:indexed-name": "Iwakawa S."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Miyakita", "ce:indexed-name": "Miyakita K."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Hashimoto", "ce:indexed-name": "Hashimoto Y."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kuroda", "ce:indexed-name": "Kuroda T."}]}, "ref-sourcetitle": "Biol Pharm Bull"}}, {"ref-fulltext": "D.M. Stresser, A.K. Mason, E.S. Perloff, T. Ho, C.L. Crespi, A.A. Dandeneau, and et al. Differential time and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine Drug Metab Dispos 37 2009 695 698", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Differential time and NADPH-dependent inhibition of CYP2C19 by enantiomers of fluoxetine"}, "refd-itemidlist": {"itemid": {"$": "61649127513", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "695", "@last": "698"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Stresser", "ce:indexed-name": "Stresser D.M."}, {"@seq": "2", "ce:initials": "A.K.", "@_fa": "true", "ce:surname": "Mason", "ce:indexed-name": "Mason A.K."}, {"@seq": "3", "ce:initials": "E.S.", "@_fa": "true", "ce:surname": "Perloff", "ce:indexed-name": "Perloff E.S."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Ho", "ce:indexed-name": "Ho T."}, {"@seq": "5", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Crespi", "ce:indexed-name": "Crespi C.L."}, {"@seq": "6", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Dandeneau", "ce:indexed-name": "Dandeneau A.A."}], "et-al": null}, "ref-sourcetitle": "Drug Metab Dispos"}}, {"ref-fulltext": "C.R. Halliday, B.C. Jones, A. Dennis, D.A. Smith, N.R. Kitteringham, and B.K. Park An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: studies with human liver microsomes and heterologous enzyme expression systems Br J Clin Pharm 40 1995 369 378", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "1995"}, "ref-title": {"ref-titletext": "An investigation of the interaction between halofantrine, CYP2D6 and CYP3A4: Studies with human liver microsomes and heterologous enzyme expression systems"}, "refd-itemidlist": {"itemid": {"$": "0028812667", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "40"}, "pagerange": {"@first": "369", "@last": "378"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.R.", "@_fa": "true", "ce:surname": "Halliday", "ce:indexed-name": "Halliday C.R."}, {"@seq": "2", "ce:initials": "B.C.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones B.C."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Dennis", "ce:indexed-name": "Dennis A."}, {"@seq": "4", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith D.A."}, {"@seq": "5", "ce:initials": "N.R.", "@_fa": "true", "ce:surname": "Kitteringham", "ce:indexed-name": "Kitteringham N.R."}, {"@seq": "6", "ce:initials": "B.K.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park B.K."}]}, "ref-sourcetitle": "Br J Clin Pharm"}}, {"ref-fulltext": "M. Yao, M. Zhu, W.M. Sinz, H. Zhang, W.G. Humphreys, A.D. Rodrigues, and et al. Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis J Pharm Biomed 44 2007 211 223", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Development and full validation of six inhibition assays for five major cytochrome P450 enzymes in human liver microsomes using an automated 96-well microplate incubation format and LC-MS/MS analysis"}, "refd-itemidlist": {"itemid": {"$": "34047252007", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "44"}, "pagerange": {"@first": "211", "@last": "223"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Yao", "ce:indexed-name": "Yao M."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Zhu", "ce:indexed-name": "Zhu M."}, {"@seq": "3", "ce:initials": "W.M.", "@_fa": "true", "ce:surname": "Sinz", "ce:indexed-name": "Sinz W.M."}, {"@seq": "4", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang H."}, {"@seq": "5", "ce:initials": "W.G.", "@_fa": "true", "ce:surname": "Humphreys", "ce:indexed-name": "Humphreys W.G."}, {"@seq": "6", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Rodrigues", "ce:indexed-name": "Rodrigues A.D."}], "et-al": null}, "ref-sourcetitle": "J Pharm Biomed"}}, {"ref-fulltext": "L. Liu, X. Pan, H.Y. Liu, X.D. Liu, H.W. Yang, L. Xie, and et al. Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans Acta Pharmacol Sin 32 2011 1285 1293", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Modulation of pharmacokinetics of theophylline by antofloxacin, a novel 8-amino-fluoroquinolone, in humans"}, "refd-itemidlist": {"itemid": {"$": "80053910068", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "1285", "@last": "1293"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu L."}, {"@seq": "2", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Pan", "ce:indexed-name": "Pan X."}, {"@seq": "3", "ce:initials": "H.Y.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu H.Y."}, {"@seq": "4", "ce:initials": "X.D.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu X.D."}, {"@seq": "5", "ce:initials": "H.W.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang H.W."}, {"@seq": "6", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Xie", "ce:indexed-name": "Xie L."}], "et-al": null}, "ref-sourcetitle": "Acta Pharmacol Sin"}}, {"ref-fulltext": "A.E. Rettie, and J.P. Jones Clinical and toxicological relevance of CYP2C9: drug-drug interactions and pharmacogenetics Annu Rev Pharmacol Toxicol 45 2005 477 494", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Clinical and toxicological relevance of CYP2C9: Drug-drug interactions and pharmacogenetics"}, "refd-itemidlist": {"itemid": {"$": "13944274619", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "45"}, "pagerange": {"@first": "477", "@last": "494"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.E.", "@_fa": "true", "ce:surname": "Rettie", "ce:indexed-name": "Rettie A.E."}, {"@seq": "2", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones J.P."}]}, "ref-sourcetitle": "Annu Rev Pharmacol Toxicol"}}, {"ref-fulltext": "C. Rowan, A.D. Brinker, P. Nourjah, J. Chang, A. Mosholder, J.S. Barrett, and et al. Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors Pharmacoepidemiol Drug Saf 18 2009 301 309", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors"}, "refd-itemidlist": {"itemid": {"$": "65449181616", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "301", "@last": "309"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Rowan", "ce:indexed-name": "Rowan C."}, {"@seq": "2", "ce:initials": "A.D.", "@_fa": "true", "ce:surname": "Brinker", "ce:indexed-name": "Brinker A.D."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Nourjah", "ce:indexed-name": "Nourjah P."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang J."}, {"@seq": "5", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Mosholder", "ce:indexed-name": "Mosholder A."}, {"@seq": "6", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Barrett", "ce:indexed-name": "Barrett J.S."}], "et-al": null}, "ref-sourcetitle": "Pharmacoepidemiol Drug Saf"}}, {"ref-fulltext": "D.P. Cronin-Fenton, and T.L. Lash Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes Expert Rev Clin Pharmacol 4 2011 363 377", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes"}, "refd-itemidlist": {"itemid": {"$": "79955979258", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "4"}, "pagerange": {"@first": "363", "@last": "377"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.P.", "@_fa": "true", "ce:surname": "Cronin-Fenton", "ce:indexed-name": "Cronin-Fenton D.P."}, {"@seq": "2", "ce:initials": "T.L.", "@_fa": "true", "ce:surname": "Lash", "ce:indexed-name": "Lash T.L."}]}, "ref-sourcetitle": "Expert Rev Clin Pharmacol"}}, {"ref-fulltext": "M. Shou, and R. Dai Analysis of in vitro cytochrome P450 inhibition in drug discovery and development D. Zhang, M. Zhu, W.G. Humphreys, Reversible inhibition: drug metabolism in drug design and development 2008 John Wiley & Sons Inc. New Jersey 515 526", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Analysis of in vitro cytochrome P450 inhibition in drug discovery and development"}, "refd-itemidlist": {"itemid": {"$": "84973434801", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "515", "@last": "526"}}, "ref-text": "D. Zhang, M. Zhu, W.G. Humphreys, John Wiley & Sons Inc. New Jersey", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Shou", "ce:indexed-name": "Shou M."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Dai", "ce:indexed-name": "Dai R."}]}, "ref-sourcetitle": "Reversible Inhibition: Drug Metabolism in Drug Design and Development"}}, {"ref-fulltext": "M. Haruna, K. Kumon, N. Yahagi, Y. Watanabe, Y. Ishida, N. Kobayashi, and et al. Blood volume measurement at the bedside using ICG pulse spectrophotometry Anesthesiology 89 1998 1322 1328", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Blood volume measurement at the bedside using ICG pulse spectrophotometry"}, "refd-itemidlist": {"itemid": {"$": "0032407548", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "89"}, "pagerange": {"@first": "1322", "@last": "1328"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Haruna", "ce:indexed-name": "Haruna M."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Kumon", "ce:indexed-name": "Kumon K."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Yahagi", "ce:indexed-name": "Yahagi N."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe Y."}, {"@seq": "5", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Ishida", "ce:indexed-name": "Ishida Y."}, {"@seq": "6", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kobayashi", "ce:indexed-name": "Kobayashi N."}], "et-al": null}, "ref-sourcetitle": "Anesthesiology"}}, {"ref-fulltext": "Y. Kimura, H. Ito, R. Ohnishi, and T. Hatano Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity Food Chem Toxicol 48 2010 429 435", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Inhibitory effects of polyphenols on human cytochrome P450 3A4 and 2C9 activity"}, "refd-itemidlist": {"itemid": {"$": "72149090100", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48"}, "pagerange": {"@first": "429", "@last": "435"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Kimura", "ce:indexed-name": "Kimura Y."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Ito", "ce:indexed-name": "Ito H."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ohnishi", "ce:indexed-name": "Ohnishi R."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Hatano", "ce:indexed-name": "Hatano T."}]}, "ref-sourcetitle": "Food Chem Toxicol"}}, {"ref-fulltext": "F.J. Gonzalez, and H.V. Gelboin Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins Drug Metab Rev 26 1994 165 183", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins"}, "refd-itemidlist": {"itemid": {"$": "0028272001", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "165", "@last": "183"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.J.", "@_fa": "true", "ce:surname": "Gonzalez", "ce:indexed-name": "Gonzalez F.J."}, {"@seq": "2", "ce:initials": "H.V.", "@_fa": "true", "ce:surname": "Gelboin", "ce:indexed-name": "Gelboin H.V."}]}, "ref-sourcetitle": "Drug Metab Rev"}}]}}}}, "affiliation": [{"affiliation-city": "Nagoya", "@id": "60161458", "affilname": "Nagoya University Graduate School of Medicine", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60161458", "affiliation-country": "Japan"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Pathum Thani", "@id": "60004391", "affilname": "Thailand National Science and Technology Development Agency", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004391", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84971320923", "dc:description": "Effects of the hydroethanolic extract of Phikud Navakot (PN), a Thai traditional remedy, on human cytochrome P450s (CYPs) were investigated in vitro. Selective substrates of CYPs were used to investigate the effects and kinetics of PN on CYP inhibition using human liver microsomes. Primary human hepatocytes were used to assess the inductive effects of PN on CYP enzyme activities and protein expressions. The results showed that PN inhibited the activities of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 with half maximal inhibitory concentration (IC50) values of 13, 62, 67, and 88 \u03bcg/mL, respectively. Meanwhile, it had no effect on the activities of CYP2C19 and CYP2E1 (IC50 > 1 mg/mL). PN exhibited competitive inhibition of CYP1A2 (Ki = 34 \u03bcg/mL), mixed type inhibition of CYP2C9 and CYP2D6 (Ki = 80 and 12 \u03bcg/mL, respectively), and uncompetitive inhibition of CYP3A4 (Ki = 150 \u03bcg/mL). PN did not have an inductive effect on CYP1A2, CYP2C9, CYP2C19 and CYP3A4 in primary human hepatocytes, which is an advantageous characteristic of the extract. However the extract may cause herb-drug interactions via inhibition of CYP1A2, CYP2C9, CYP2D6 and CYP3A4, and precautions should be taken when PN is coadministered with drugs that are metabolized by these CYP enzymes.", "pubmed-id": "27212065", "prism:coverDate": "2016-06-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84971320923", "dc:creator": {"author": [{"ce:given-name": "Abhiruj", "preferred-name": {"ce:given-name": "Abhiruj", "ce:initials": "A.", "ce:surname": "Chiangsom", "ce:indexed-name": "Chiangsom A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chiangsom", "@auid": "57189455670", "author-url": "https://api.elsevier.com/content/author/author_id/57189455670", "ce:indexed-name": "Chiangsom A."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84971320923"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84971320923&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84971320923&origin=inward"}], "source-id": "144956", "pii": "S1347436716300179", "citedby-count": "6", "prism:volume": "31", "subtype": "ar", "dc:title": "Inhibitory and inductive effects of Phikud Navakot extract on human cytochrome P450", "openaccess": "0", "prism:issn": "18800920 13474367", "publishercopyright": "\u00a9 2016 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.", "prism:issueIdentifier": "3", "subtypeDescription": "Article", "prism:publicationName": "Drug Metabolism and Pharmacokinetics", "prism:pageRange": "210-217", "prism:endingPage": "217", "openaccessFlag": "false", "prism:doi": "10.1016/j.dmpk.2016.04.002", "prism:startingPage": "210", "dc:identifier": "SCOPUS_ID:84971320923", "dc:publisher": "Japanese Society for the Study of Xenobioticsjssx@imic.or.jp"}, "idxterms": {"mainterm": [{"$": "Cells, Cultured", "@weight": "b", "@candidate": "n"}, {"$": "Cytochrome P-450 Enzyme Inducers", "@weight": "b", "@candidate": "n"}, {"$": "Cytochrome P-450 Enzyme Inhibitors", "@weight": "b", "@candidate": "n"}, {"$": "Cytochrome P-450 Enzyme System", "@weight": "b", "@candidate": "n"}, {"$": "Hepatocytes", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Kinetics", "@weight": "b", "@candidate": "n"}, {"$": "Plant Extracts", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Cytochrome P450"}, {"@_fa": "true", "$": "Drug interaction"}, {"@_fa": "true", "$": "Induction"}, {"@_fa": "true", "$": "Inhibition"}, {"@_fa": "true", "$": "Phikud Navakot"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pharmacology", "@code": "3004", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmaceutical Science", "@code": "3003", "@abbrev": "PHAR"}, {"@_fa": "true", "$": "Pharmacology (medical)", "@code": "2736", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Abhiruj", "preferred-name": {"ce:given-name": "Abhiruj", "ce:initials": "A.", "ce:surname": "Chiangsom", "ce:indexed-name": "Chiangsom A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Chiangsom", "@auid": "57189455670", "author-url": "https://api.elsevier.com/content/author/author_id/57189455670", "ce:indexed-name": "Chiangsom A."}, {"ce:given-name": "Somsong", "preferred-name": {"ce:given-name": "Somsong", "ce:initials": "S.", "ce:surname": "Lawanprasert", "ce:indexed-name": "Lawanprasert S."}, "@seq": "2", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Lawanprasert", "@auid": "6504371267", "author-url": "https://api.elsevier.com/content/author/author_id/6504371267", "ce:indexed-name": "Lawanprasert S."}, {"ce:given-name": "Shingo", "preferred-name": {"ce:given-name": "Shingo", "ce:initials": "S.", "ce:surname": "Oda", "ce:indexed-name": "Oda S."}, "@seq": "3", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60161458", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60161458"}, "ce:surname": "Oda", "@auid": "36661277500", "author-url": "https://api.elsevier.com/content/author/author_id/36661277500", "ce:indexed-name": "Oda S."}, {"ce:given-name": "Kornphimol", "preferred-name": {"ce:given-name": "Kornphimol", "ce:initials": "K.", "ce:surname": "Kulthong", "ce:indexed-name": "Kulthong K."}, "@seq": "4", "ce:initials": "K.", "@_fa": "true", "affiliation": {"@id": "60004391", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004391"}, "ce:surname": "Kulthong", "@auid": "35784698300", "author-url": "https://api.elsevier.com/content/author/author_id/35784698300", "ce:indexed-name": "Kulthong K."}, {"ce:given-name": "Rataya", "preferred-name": {"ce:given-name": "Rataya", "ce:initials": "R.", "ce:surname": "Luechapudiporn", "ce:indexed-name": "Luechapudiporn R."}, "@seq": "5", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Luechapudiporn", "@auid": "13606193100", "author-url": "https://api.elsevier.com/content/author/author_id/13606193100", "ce:indexed-name": "Luechapudiporn R."}, {"ce:given-name": "Tsuyoshi", "preferred-name": {"ce:given-name": "Tsuyoshi", "ce:initials": "T.", "ce:surname": "Yokoi", "ce:indexed-name": "Yokoi T."}, "@seq": "6", "ce:initials": "T.", "@_fa": "true", "affiliation": {"@id": "60161458", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60161458"}, "ce:surname": "Yokoi", "@auid": "7201620434", "author-url": "https://api.elsevier.com/content/author/author_id/7201620434", "ce:indexed-name": "Yokoi T."}, {"ce:given-name": "Rawiwan", "preferred-name": {"ce:given-name": "Rawiwan", "ce:initials": "R.", "ce:surname": "Maniratanachote", "ce:indexed-name": "Maniratanachote R."}, "@seq": "7", "ce:initials": "R.", "@_fa": "true", "affiliation": {"@id": "60004391", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004391"}, "ce:surname": "Maniratanachote", "@auid": "8936773600", "author-url": "https://api.elsevier.com/content/author/author_id/8936773600", "ce:indexed-name": "Maniratanachote R."}]}}}